The efficiency of the symptom-based score in infants diagnosed with cow's milk protein and hen's egg allergy.


Journal

Allergologia et immunopathologia
ISSN: 1578-1267
Titre abrégé: Allergol Immunopathol (Madr)
Pays: Singapore
ID NLM: 0370073

Informations de publication

Date de publication:
Historique:
received: 30 06 2018
revised: 08 09 2018
accepted: 12 09 2018
pubmed: 7 12 2018
medline: 9 8 2019
entrez: 4 12 2018
Statut: ppublish

Résumé

Symptom-based score (SBS) quantifies the number and severity of suspected cow's milk-related symptoms. In this study, we aimed to evaluate the efficiency of SBS in patients diagnosed with cow's milk protein (CMPA) and hen's egg allergy (HEA). A single-center study was conducted between June 2015 and August 2017. Infants who were diagnosed with CMPA and HEA or both were enrolled in the study. SBS was applied at baseline and at one month during an elimination diet. One hundred and twelve patients were enrolled in the study. Of these, 56 (50%) were female. Forty-nine (43.8%) patients were diagnosed with CMPA, 39 (34.8%) patients were diagnosed with HEA and 24 (21.4%) patients were diagnosed with cow's milk protein and hen's egg allergy (CMPHEA). In the analysis of SBS, median Bristol scale and initial total symptom-based scores were significantly lower in the HEA group than others (p=0.002; p=0.025). After the elimination diet, mean SBS decrease in the CMPHEA group (11.3±4.7) was found to be higher than CMPA (8.8±3.7) and HEA (8.0±4.0) groups (p=0.009). In 41 (83.7%) patients with CMPA, 33 (84.6%) patients with HEA and 21 (87.5%) patients with CMPHEA, a ≥50% decrease in SBS was observed after the elimination diet. We may conclude that the present study suggests that SBS can be useful in monitoring the response to elimination diet in infants diagnosed with cow's milk protein and hen's egg allergy.

Identifiants

pubmed: 30501905
pii: S0301-0546(18)30141-1
doi: 10.1016/j.aller.2018.09.006
pii:
doi:

Substances chimiques

Allergens 0
Egg Proteins 0
Milk Proteins 0

Types de publication

Journal Article

Langues

eng

Pagination

265-271

Informations de copyright

Copyright © 2018 SEICAP. Published by Elsevier España, S.L.U. All rights reserved.

Auteurs

Seda Sirin Kose (S)

Dokuz Eylul University, Division of Pediatric Immunology and Allergy, Izmir, Turkey. Electronic address: sedasirin85@yahoo.com.

G Atakul (G)

Dokuz Eylul University, Division of Pediatric Immunology and Allergy, Izmir, Turkey.

S Asilsoy (S)

Dokuz Eylul University, Division of Pediatric Immunology and Allergy, Izmir, Turkey.

N Uzuner (N)

Dokuz Eylul University, Division of Pediatric Immunology and Allergy, Izmir, Turkey.

O Anal (O)

Dokuz Eylul University, Division of Pediatric Immunology and Allergy, Izmir, Turkey.

O Karaman (O)

Dokuz Eylul University, Division of Pediatric Immunology and Allergy, Izmir, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH